Innovation in pharmaceutical R&D: mapping the research landscape

被引:14
|
作者
Romasanta, Angelo Kenneth S. [1 ,2 ]
van der Sijde, Peter [1 ]
Van Muijlwijk-Koezen, Jacqueline [2 ]
机构
[1] Vrije Univ Amsterdam, Sci Business & Innovat, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst AIMMS, Amsterdam, Netherlands
基金
欧盟地平线“2020”;
关键词
Pharmaceutical industry; Drug development; Innovation; Research and development; ABSORPTIVE-CAPACITY; INTERORGANIZATIONAL COLLABORATION; TECHNOLOGICAL-CHANGE; EXTERNAL KNOWLEDGE; PARTNER SELECTION; NETWORK DYNAMICS; DRUG DEVELOPMENT; STRATEGIC GROUPS; HIGH-TECH; INDUSTRY;
D O I
10.1007/s11192-020-03707-y
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
In response to the increasing number and breadth of innovation studies on the pharmaceutical industry, we mapped the literature to show the trends in recent research and to indicate areas for further research. In the first phase, we analyzed articles on the pharmaceutical industry published in innovation journals. We used these articles' textual and citation data and applied hybrid cluster analysis. Three main clusters were produced based on the level of analysis innovation scholars had used to investigate the industry: macro, meso and micro. We describe the research topics within these clusters and show that, overall, innovation scholars increasingly focus on the meso-level, analyzing the relationships across different firms. This shift in interest toward the collaborative nature of drug discovery and development was also apparent in macro- and micro-level studies. To explore how this literature is used by scientists in the industry, our second phase involved analysis of the citing articles published in pharmaceutical journals. Using our findings, we propose research areas that can be further explored in order to create an engaged and better-integrated literature on pharmaceutical innovation.
引用
收藏
页码:1801 / 1832
页数:32
相关论文
共 50 条
  • [1] Innovation in pharmaceutical R&D: mapping the research landscape
    Angelo Kenneth S. Romasanta
    Peter van der Sijde
    Jacqueline van Muijlwijk-Koezen
    [J]. Scientometrics, 2020, 125 : 1801 - 1832
  • [2] ReRouting biomedical innovation: observations from a mapping of the alternative research and development (R&D) landscape
    Greenberg, Alexandra
    Kiddell-Monroe, Rachel
    [J]. GLOBALIZATION AND HEALTH, 2016, 12
  • [3] ReRouting biomedical innovation: observations from a mapping of the alternative research and development (R&D) landscape
    Alexandra Greenberg
    Rachel Kiddell-Monroe
    [J]. Globalization and Health, 12
  • [4] Mapping research on R&D, innovation and productivity: a study of an academic endeavour
    Brostrom, Anders
    Karlsson, Staffan
    [J]. ECONOMICS OF INNOVATION AND NEW TECHNOLOGY, 2017, 26 (1-2) : 6 - 20
  • [5] A decade of innovation in pharmaceutical R&D: the Chorus model
    Paul K. Owens
    Eyas Raddad
    Jeffrey W. Miller
    John R. Stille
    Kenneth G. Olovich
    Neil V. Smith
    Rosie S. Jones
    Joel C. Scherer
    [J]. Nature Reviews Drug Discovery, 2015, 14 : 17 - 28
  • [6] R&D in the pharmaceutical industry and the US investment in innovation
    Wollowitz, S
    Kermani, F
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U251 - U251
  • [7] A decade of innovation in pharmaceutical R&D: the Chorus model
    Owens, Paul K.
    Raddad, Eyas
    Miller, Jeffrey W.
    Stille, John R.
    Olovich, Kenneth G.
    Smith, Neil V.
    Jones, Rosie S.
    Scherer, Joel C.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (01) : 17 - 28
  • [8] Public subsidies for R&D and public sector pharmaceutical innovation
    Kourouklis, Dimitrios
    [J]. APPLIED ECONOMICS, 2021, 53 (32) : 3759 - 3777
  • [9] Racing to define pharmaceutical R&D external innovation models
    Wang, Liangsu
    Plump, Andrew
    Ringel, Michael
    [J]. DRUG DISCOVERY TODAY, 2015, 20 (03) : 361 - 370
  • [10] Innovation deficit revisited: reflections on the productivity of pharmaceutical R&D
    Drews, J
    [J]. DRUG DISCOVERY TODAY, 1998, 3 (11) : 491 - 494